Here's what OBJ need to do:
1. Stop looking at HC, if they do.
2. Continue to focus on the very difficult task of commercialising technology, nurturing those relationships and listening to what their partners (potential partners) actually need.
3. Very carefully select the other technologies they'll continue attempting to develop (I worry this list remains too long).
4. Develop those other technologies with continued careful management of cash.
5. Get some expert advice on the pros and cons of going it along with any of their technology commercialisation aspirations (this also worries me as they are not structured for this as far as I can tell)
6. Engage someone to help tell their story with their target audience being analysts / fund managers (especially in the small cap space). A CFO with a good track record with analysts might be a good fit and could also help with 4 and 5. This will mean $ for a salary etc. but if it means increasing the odds of a better outcome on 4 to 6 then well worth it.
- Forums
- ASX - By Stock
- Xmas Day launch on Amazon USA
Here's what OBJ need to do: 1. Stop looking at HC, if they do....
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WFL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online